2026 Q2 Portfolio Activity
In 2026 Q2, Blue Owl Capital Holdings LP maintained a portfolio of 97 distinct positions. The most significant new addition was CAPITAL ONE FINL CORP, now representing 3.62% of the total fund value. They heavily accumulated shares in SPACE EXPLORATION TECHN CORP, increasing the position by 214.7%. The fund also reduced its exposure to AKTIS ONCOLOGY INC by 85.9%.
Position History
hover any row below to update
Loading…
Total Positions
97
Quarter
2026 Q2
Top Holding
N/A (36.0%)
Top 10 Concentration
78.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 97
Blue Owl Capital Holdings LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
SPACE EXPLORATI...
|
|
Unknown | 35.97% | — |
#1
Prev: #—
|
9.5 |
—
|
1,398,815 | — |
NEW
|
1,398,815 | $239,001,531 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
N/A
AKTIS ONCOLOGY ...
|
|
Unknown | 14.89% | 15.20% |
#2
1
Prev: #1
|
6.0 |
—
|
-91,129 | -2.9% |
P
S
|
3,070,219 | $98,953,158 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 4.22% | 7.29% |
#3
2
Prev: #5
|
3.2 |
—
|
-370,000 | -19.4% |
P
S
|
1,539,764 | $28,039,102 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 4.21% | 8.61% |
#4
2
Prev: #2
|
4.7 |
—
|
2,043,150 | 28.7% |
P
S
|
9,163,157 | $27,947,629 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
NCDL
NUVEEN CHURCHIL...
|
Financial Services | 4.01% | 7.33% |
#5
1
Prev: #4
|
3.1 |
—
|
no change | no change |
P
S
|
2,143,626 | $26,623,835 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 3.94% | 5.49% |
#6
1
Prev: #7
|
1.6 |
—
|
-276,000 | -27.4% |
P
S
|
729,929 | $26,160,655 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
COF
CAPITAL ONE FIN...
|
Financial Services | 3.62% | — |
#7
Prev: #—
|
4.9 |
—
|
119,757 | — |
NEW
|
119,757 | $24,025,649 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
OBDC
BLUE OWL CAPITA...
|
Financial Services | 3.35% | 6.08% |
#8
2
Prev: #6
|
2.3 |
—
|
no change | no change |
P
S
|
2,045,070 | $22,229,911 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
DEEP FISSION IN...
|
|
Unknown | 2.22% | — |
#9
Prev: #—
|
4.4 |
—
|
1,333,333 | — |
NEW
|
1,333,333 | $14,719,996 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
DELL
DELL TECHNOLOGI...
|
Technology | 2.14% | 0.61% |
#10
20
Prev: #30
|
3.9 |
—
|
19,062 | 137.1% |
P
S
|
32,961 | $14,221,353 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
HLLY
HOLLEY INC
|
Consumer Cyclical | 1.68% | 3.49% |
#11
1
Prev: #10
|
1.2 |
—
|
140,000 | 3.3% |
P
S
|
4,376,888 | $11,161,064 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
EYPT
EYEPOINT INC
|
Healthcare | 1.64% | 3.16% |
#12
1
Prev: #11
|
1.2 |
—
|
-150,000 | -16.4% |
P
S
|
762,594 | $10,905,094 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
SGMT
SAGIMET BIOSCIE...
|
Healthcare | 1.47% | 0.47% |
#13
20
Prev: #33
|
3.6 |
—
|
926,667 | 277.5% |
P
S
|
1,260,544 | $9,744,005 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 1.37% | 2.14% |
#14
2
Prev: #12
|
2.5 |
—
|
63,600 | 11.7% |
P
S
|
608,600 | $9,092,484 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 1.28% | — |
#15
Prev: #—
|
4.0 |
—
|
874,542 | — |
NEW
|
874,542 | $8,483,057 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 1.19% | 4.18% |
#16
8
Prev: #8
|
3.0 |
—
|
682,551 | 23.2% |
P
S
|
3,624,076 | $7,936,726 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CNDT
CONDUENT INC
|
Technology | 1.11% | 1.73% |
#17
4
Prev: #13
|
1.4 |
—
|
no change | no change |
P
S
|
5,036,595 | $7,353,429 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.03% | 1.44% |
#18
2
Prev: #16
|
1.4 |
—
|
no change | no change |
P
S
|
61,455 | $6,823,349 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 0.96% | — |
#19
Prev: #—
|
3.9 |
—
|
450,000 | — |
NEW
|
450,000 | $6,367,500 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.92% | 1.70% |
#20
6
Prev: #14
|
0.4 |
—
|
-120,000 | -39.7% |
P
S
|
182,638 | $6,098,283 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.83% | 1.05% |
#21
4
Prev: #25
|
2.3 |
—
|
5,000 | 16.0% |
P
S
|
36,259 | $5,541,100 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
IMA
IMAGENEBIO INC
|
Healthcare | 0.81% | 1.29% |
#22
3
Prev: #19
|
0.8 |
—
|
-41,645 | -4.3% |
P
S
|
917,692 | $5,414,383 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
CALL
COMPASS PATHWAY...
|
|
CALL Option | 0.78% | — |
#23
Prev: #—
|
3.8 |
—
|
1,670,500 | — |
NEW
|
1,670,500 | $5,180,485 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.72% | — |
#24
Prev: #—
|
3.8 |
—
|
260,000 | — |
NEW
|
260,000 | $4,776,200 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 0.68% | 1.34% |
#25
7
Prev: #18
|
0.3 |
—
|
-110,000 | -20.1% |
P
S
|
437,552 | $4,511,161 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.65% | 0.51% |
#26
6
Prev: #32
|
3.3 |
—
|
250,000 | 166.7% |
P
S
|
400,000 | $4,332,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
LENZ
LENZ THERAPEUTI...
|
Healthcare | 0.65% | 1.25% |
#27
6
Prev: #21
|
2.8 |
—
|
250,000 | 49.3% |
P
S
|
756,722 | $4,298,181 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
AQST
AQUESTIVE THERA...
|
Healthcare | 0.59% | 1.50% |
#28
13
Prev: #15
|
0.2 |
—
|
-405,000 | -30.0% |
P
S
|
942,932 | $3,922,597 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
STWD
STARWOOD PPTY T...
|
Real Estate | 0.48% | 0.73% |
#29
2
Prev: #27
|
2.7 |
—
|
37,810 | 23.8% |
P
S
|
196,355 | $3,216,295 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 0.36% | 0.62% |
#30
1
Prev: #29
|
3.1 |
—
|
80,000 | 80.0% |
P
S
|
180,000 | $2,392,200 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
ELDN
ELEDON PHARMACE...
|
Healthcare | 0.34% | 1.18% |
#31
9
Prev: #22
|
0.1 |
—
|
-853,403 | -60.1% |
P
S
|
566,509 | $2,232,045 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CABA
CABALETTA BIO I...
|
Healthcare | 0.33% | — |
#32
Prev: #—
|
3.6 |
—
|
714,710 | — |
NEW
|
714,710 | $2,222,748 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CHYM
CHIME FINL INC
|
Technology | 0.28% | — |
#33
Prev: #—
|
3.6 |
—
|
89,878 | — |
NEW
|
89,878 | $1,840,701 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CNTX
CONTEXT THERAPE...
|
Healthcare | 0.24% | 3.58% |
#34
25
Prev: #9
|
0.1 |
—
|
-2,155,000 | -42.3% |
P
S
|
2,934,015 | $1,625,151 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
WW
WW INTL INC
|
Healthcare | 0.20% | 0.35% |
#35
1
Prev: #34
|
0.6 |
—
|
-11,235 | -11.7% |
P
S
|
84,399 | $1,348,696 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
MRKR
MARKER THERAPEU...
|
Healthcare | 0.12% | 0.19% |
#36
3
Prev: #39
|
1.0 |
—
|
no change | no change |
P
S
|
554,250 | $814,748 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
CALL
ERASCA INC
|
|
CALL Option | 0.12% | — |
#37
Prev: #—
|
3.5 |
—
|
100,000 | — |
NEW
|
100,000 | $795,000 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 0.12% | 0.70% |
#38
10
Prev: #28
|
1.0 |
—
|
no change | no change |
P
S
|
733,568 | $784,918 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
CYBN
CYBIN INC
|
Unknown | 0.06% | — |
#39
Prev: #—
|
3.5 |
—
|
59,911 | — |
NEW
|
59,911 | $396,012 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
FLD
FOLD HLDGS INC
|
Financial Services | 0.06% | 0.30% |
#40
3
Prev: #37
|
1.0 |
—
|
no change | no change |
P
S
|
856,632 | $385,484 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
NIOBW
NIOCORP DEVS LT...
|
Unknown | 0.06% | 0.14% |
#41
Prev: #41
|
0.5 |
—
|
-51,820 | -16.2% |
P
S
|
268,280 | $380,958 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
CALL
ELEDON PHARMACE...
|
|
CALL Option | 0.04% | — |
#42
Prev: #—
|
3.5 |
—
|
200,000 | — |
NEW
|
200,000 | $285,000 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
RZLVW
REZOLVE AI PLC
|
Unknown | 0.03% | 0.05% |
#43
2
Prev: #45
|
1.0 |
—
|
no change | no change |
P
S
|
235,121 | $213,960 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
BNAIW
BRAND ENGAGEMEN...
|
Unknown | 0.03% | 0.11% |
#44
1
Prev: #43
|
0.5 |
—
|
-213,000 | -12.8% |
P
S
|
1,453,808 | $203,533 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
PIPER SANDLER C...
|
|
Unknown | 0.03% | 0.05% |
#45
1
Prev: #46
|
1.0 |
—
|
no change | no change |
P
S
|
2,428 | $175,642 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
N/A
ENGENE THERAPEU...
|
|
Unknown | 0.02% | — |
#46
Prev: #—
|
3.5 |
—
|
511,177 | — |
NEW
|
511,177 | $148,190 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
N/A
CALL
LARIMAR THERAPE...
|
|
CALL Option | 0.02% | — |
#47
Prev: #—
|
3.5 |
—
|
728,600 | — |
NEW
|
728,600 | $145,720 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
CELC
CELCUITY INC
|
Healthcare | 0.02% | — |
#48
Prev: #—
|
3.5 |
—
|
1,249 | — |
NEW
|
1,249 | $130,670 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-11 | |||
|
N/A
CALL
COMPASS THERAPE...
|
|
CALL Option | 0.02% | — |
#49
Prev: #—
|
3.5 |
—
|
303,800 | — |
NEW
|
303,800 | $106,330 | — | 13F Filing | 2026-06-30 | 2026-08-11 | ||
|
N/A
STABLECOINX INC
|
|
Unknown | 0.02% | — |
#50
Prev: #—
|
3.5 |
—
|
250,000 | — |
NEW
|
250,000 | $102,500 | — | 13F Filing | 2026-06-30 | 2026-08-11 |
Showing 1-50 of 97 holdings